By Meredith Salisbury
Nasdaq’s delisting warning notice has become so common among genomics companies that it was a refreshing change to see the news that GTI member Lion Bioscience was actually being added to a new index.
Did Someone Say Blue Chip?
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.